glp 1 agonist and dpp 4 inhibitor GLP-1 receptor versus DPP-4 kidney and cardiovascular outcomes in clinical practice in type-2 diabetes GLP 1 Receptor Agonists and

Meta-analyses and trials in adults have consistently shown that GLP-1 RA therapy lowers body weight by 5%15% depending on agent and dose (30)

Ma T, Lu W, Wang Y, Qian P, Tian H, Gao X, et al

Efficacy and safety of lixisenatide once-daily morning or evening injections in type 2 diabetes inadequately controlled on metformin (GetGoal-M)

The study utilized a single-blind, randomized, placebo-controlled, crossover design, combined with functional magnetic resonance imaging (fMRI), to analyze the performance of 54 participants (30 with normal insulin sensitivity and 24 with impaired insulin sensitivity) on sensory associative learning tasks while receiving liraglutide and placebo treatments

( Erratum in: Int J Clin Pract

Gastrointestinal side effects may still occur even at reduced doses